Guangdong Jiaying Pharmaceutical Co., Ltd. (002198)
Guangdong Jiaying Pharmaceutical Co., Ltd. is a Chinese patent medicine enterprise integrating R & D, production and sales. The company was restructured from Meizhou pharmaceutical factory in Guangdong Province in 2003 and was listed on Shenzhen Stock Exchange in December 2007. Stock abbreviation: Jiaying pharmaceutical, stock code: 002198. At present, the company has two drug R & D, production and sales bases in Changsha City, Hunan Province and Meizhou City, Guangdong Province, with total assets of more than 1 billion yuan and market value of more than 6 billion yuan.
The company has a total of 5 dosage forms, 70 drug approval numbers, products related to throat class, cold class, orthopedics class, rheumatism class, gynecological class, heat class, tonic class, gastrointestinal class. The main products are Shuangliao Houfeng powder, chongganling tablet, Jiegu Qili tablet (capsule), Shufeng Huoluo tablet, Tiaojing Huoxue tablet, etc., all of which are protected by national traditional Chinese medicine and national patent. Shuangliao Houfeng powder is a folk secret recipe developed in Qing Dynasty, which has a history of nearly 300 years. Its production process is unique, curative effect is exact, and it is widely used. It has a high popularity and reputation in throat medicine, and is welcomed by consumers.
The company has set up marketing offices in 30 provincial capitals and established stable cooperative relations with thousands of pharmaceutical companies and more than 2000 medical institutions. At present, the company has more than 90 scientific and technological personnel and more than 1000 production and sales staff. It has established a cooperative relationship of "production, learning and research" collaborative innovation with many universities and scientific research institutes. It has strong strength in new product R & D and is at the front end of the industry. The value of raw materials, the scale and technological content of extraction and deep processing projects of traditional Chinese medicine are benchmarking in the industry, which is of great strategic significance to develop the international market.